Large-scale testing (Phase 3)Study completedNCT05330975
What this trial is testing
MRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age
Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 3,317